AbCellera Biologics Inc.
AbCellera Biologics Inc.
AbCellera Biologics Inc. (ABCL) — SEC Financial Statements & Analysis
AbCellera Biologics Inc. (ABCL) files its annual 10-K and quarterly 10-Q reports directly with the SEC. The financial data below is sourced as-filed from EDGAR — balance sheet, income statement, and cash flow as reported, without normalization or third-party adjustments.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 77 | 62 | 83 | 92 | 159 | 56 | 127 | 148 | 124 | 52 | 172 | 180 | |||||
Available For Sale Securities Debt Securities | 428 | 405 | 413 | 461 | 446 | 469 | 516 | 522 | 574 | 627 | 613 | 616 | |||||
Restricted Cash | - | - | - | - | - | - | - | - | - | - | 25 | 25 | |||||
Cash Cash Equivalents And Short Term Investments | 505 | 534 | 496 | 553 | 605 | 626 | 643 | 670 | 698 | 761 | - | - | |||||
Restricted Cash Current | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | - | - | |||||
Other Assets Current | 98 | 111 | 133 | 117 | 95 | 67 | 43 | 40 | 57 | 56 | 71 | 64 | |||||
Assets Current | 665 | 728 | 695 | 742 | 765 | 751 | 743 | 772 | 814 | 872 | 920 | 931 | |||||
Assets Noncurrent | |||||||||||||||||
Property Plant And Equipment Net | - | - | - | - | - | - | - | - | - | - | 277 | 260 | |||||
Intangible Assets Net Excluding Goodwill | 37 | 38 | 39 | 40 | 41 | 42 | 53 | 86 | 119 | 120 | 124 | 127 | |||||
Goodwill | 48 | 48 | 48 | 48 | 48 | 48 | 48 | 48 | 48 | 48 | 48 | 48 | |||||
Investments In Affiliates Subsidiaries Associates … | 65 | 63 | 93 | 90 | 82 | 82 | 84 | 76 | 72 | 66 | 63 | 59 | |||||
Other Assets Noncurrent | 69 | 52 | 53 | 57 | 62 | 97 | 134 | 113 | 105 | 94 | 81 | 113 | |||||
Assets Noncurrent | 643 | 629 | 661 | 660 | 579 | 609 | 650 | 641 | 649 | 616 | 593 | 606 | |||||
Assets | 1,307 | 1,357 | 1,356 | 1,402 | 1,344 | 1,361 | 1,393 | 1,412 | 1,463 | 1,488 | 1,512 | 1,537 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable And Other Accrued Liabilities | - | - | - | - | - | - | - | - | - | - | 36 | 52 | |||||
Accounts Payable And Other Accrued Liabilities Cur… | 40 | 51 | 53 | 50 | 48 | 55 | 54 | 44 | 43 | 50 | - | - | |||||
Business Combination Contingent Consideration Liab… | - | 0 | 0 | 0 | 9 | 8 | 20 | 20 | 51 | 50 | 54 | 55 | |||||
Accrued Royalties Current | - | - | - | - | - | - | - | - | - | - | 3 | 3 | |||||
Contract With Customer Liability Current | 8 | 14 | 16 | 17 | 19 | 14 | 6 | 6 | 11 | 19 | 18 | 9 | |||||
Liabilities Current | 47 | 64 | 69 | 67 | 75 | 77 | 80 | 70 | 105 | 119 | 110 | 119 | |||||
Liabilities Noncurrent | |||||||||||||||||
Operating Lease Liability Noncurrent | 134 | 137 | 137 | 137 | 63 | 61 | 66 | 66 | 68 | 71 | 75 | 78 | |||||
Contract With Customer Liability Noncurrent | - | - | 6 | 12 | 14 | 6 | 8 | 8 | 9 | 8 | 16 | 28 | |||||
Government Assistance Liability Noncurrent | 176 | 174 | 169 | 168 | 157 | 150 | 142 | 124 | - | 96 | - | - | |||||
Deferred Income Tax Liabilities Net | - | 9 | 10 | 10 | 10 | 10 | 13 | 22 | 30 | 31 | 33 | 33 | |||||
Other Liabilities Noncurrent | 11 | 5 | 1 | 2 | 2 | 7 | 2 | 6 | 6 | 6 | 5 | 2 | |||||
Business Combination Contingent Consideration Liab… | - | - | - | - | - | 0 | 4 | 4 | 5 | 5 | 5 | 6 | |||||
Liabilities Noncurrent | 322 | 326 | 323 | 328 | 246 | 228 | 235 | 231 | 228 | 217 | 219 | 223 | |||||
Liabilities | 369 | 390 | 392 | 395 | 321 | 304 | 315 | 302 | 333 | 336 | 329 | 342 | |||||
Stockholders Equity | |||||||||||||||||
Common Stock Value | 817 | 802 | 794 | 792 | 790 | 777 | 773 | 770 | 765 | 753 | 748 | 745 | |||||
Additional Paid In Capital Common Stock | 197 | 198 | 193 | 181 | 169 | 166 | 155 | 141 | 128 | 121 | 109 | 96 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -2 | -4 | -3 | -3 | -7 | -4 | -1 | -2 | -2 | -2 | -1 | -2 | |||||
Retained Earnings Accumulated Deficit | -73 | -29 | -21 | 37 | 71 | 117 | 151 | 202 | 239 | 280 | 327 | 356 | |||||
Stockholders Equity | 938 | 967 | 964 | 1,007 | 1,023 | 1,056 | 1,078 | 1,111 | 1,130 | 1,152 | 1,183 | 1,195 | |||||
Liabilities And Stockholders Equity | 1,307 | 1,357 | 1,356 | 1,402 | 1,344 | 1,361 | 1,393 | 1,412 | 1,463 | 1,488 | 1,512 | 1,537 | |||||
Common Stock No Par Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Shares Issued | 304 | 301 | 299 | 296 | 296 | 296 | 291 | 291 | 291 | 291 | 287 | 287 | |||||
Shares Outstanding | 304 | 301 | 299 | 296 | 296 | 296 | 291 | 291 | 291 | 291 | 287 | 287 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 7.05% | 54.48% | - | - | - | - | - | - | - | - | - | - |
| 2025 | 0.50% | 79.60% | 154.23% | -1.42% | 11.79% | 33.49% | -17.66% | -20.97% | -6.40% | 5.59% | 24.53% | 27.02% |
| 2024 | -2.97% | -26.73% | -19.31% | -10.18% | -8.42% | -4.56% | 4.15% | 3.46% | 20.42% | -16.44% | -17.12% | -30.48% |
| 2023 | - | - | - | -20.95% | -28.26% | -38.02% | 0.00% | 28.44% | 18.28% | -11.30% | -18.27% | -27.87% |
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 50+ calculated metrics
Subscribe to unlock 17+ years of data and 50+ calculated metrics
Performance and Valuation Metrics
Metrics | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 14.05 | 11.32 | 10.10 | 11.07 | 10.15 | 9.81 | 9.34 | 10.96 | 7.76 | 7.33 | 8.34 | 7.83 | |||||
| Quick Ratio | 14.05 | 11.32 | 10.10 | 11.07 | 10.15 | 9.81 | 9.34 | 10.96 | 7.76 | 7.33 | 8.34 | 7.83 | |||||
| Working Capital | 617.30M | 663.93M | 626.34M | 675.12M | 689.58M | 674.76M | 663.32M | 701.17M | 709.07M | 752.97M | 809.28M | 811.83M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.39 | 0.40 | 0.41 | 0.39 | 0.31 | 0.29 | 0.29 | 0.27 | 0.29 | 0.29 | 0.28 | 0.29 | |||||
| Debt Ratio | 0.28 | 0.29 | 0.29 | 0.28 | 0.24 | 0.22 | 0.23 | 0.21 | 0.23 | 0.23 | 0.22 | 0.22 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.06 | 0.06 | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 | 0.09 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -0.47 | -0.49 | -0.57 | -0.55 | -0.56 | -0.55 | -0.60 | -0.52 | -0.50 | -0.51 | -0.45 | -0.26 | |||||
| Free Cash Flow Per Share TTM | -0.62 | -0.58 | -0.51 | -0.47 | -0.48 | -0.64 | -0.67 | -0.58 | -0.44 | -0.42 | -0.24 | -0.65 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Operating Profit Margin TTM | -267.60% | -288.98% | -739.68% | -847.64% | -1,395.40% | -1,091.69% | -934.61% | -814.70% | -634.94% | -623.82% | -414.63% | -80.11% | |||||
| Net Profit Margin TTM | -181.74% | -194.88% | -486.02% | -503.92% | -726.26% | -564.83% | -533.33% | -463.79% | -410.48% | -385.00% | -256.28% | -50.91% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 242.68% | 160.56% | 7.16% | -0.54% | -35.41% | -24.17% | -34.59% | -77.23% | -80.23% | -92.17% | -91.65% | -71.38% | |||||
| Net Income Growth (1Y) | -14.24% | -10.10% | -2.34% | 8.07% | 14.28% | 11.24% | 36.13% | 107.42% | 192.84% | -192.35% | -152.00% | -136.89% | |||||
| EPS Growth (1Y) | -15.77% | -11.42% | -3.66% | 6.51% | 12.37% | 9.29% | 33.66% | 103.68% | 187.88% | -191.04% | -151.25% | -136.35% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -7.35 | -6.98 | -8.76 | -6.18 | -3.95 | -5.30 | -4.36 | -5.68 | -9.03 | -11.28 | -10.31 | -25.25 | |||||
| P/B | 1.13 | 1.06 | 1.56 | 1.02 | 0.65 | 0.82 | 0.71 | 0.78 | 1.17 | 1.43 | 1.13 | 1.56 | |||||
| P/S TTM | 13.35 | 13.60 | 42.56 | 31.14 | 28.72 | 29.91 | 23.26 | 26.35 | 37.05 | 43.42 | 26.43 | 12.86 | |||||
| Market Cap | 1.06B | 1.02B | 1.50B | 1.02B | 663.85M | 862.38M | 766.62M | 870.88M | 1.33B | 1.65B | 1.33B | 1.87B | |||||
| Enterprise Value | 955.67M | 868.07M | 1.40B | 906.45M | 479.59M | 681.05M | 614.98M | 697.57M | 1.18B | 1.49B | 1.13B | 1.66B | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -189.23M | -174.07M | -153.11M | -138.99M | -143.29M | -186.95M | -197.36M | -170.40M | -127.63M | -120.82M | -68.20M | -187.06M | |||||
| Net Debt | -102.06M | -153.51M | -108.16M | -117.44M | -184.27M | -181.33M | -151.64M | -173.31M | -148.57M | -158.32M | -197.42M | -204.75M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data